| The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil JE Golub, V Saraceni, SC Cavalcante, AG Pacheco, LH Moulton, BS King, ... Aids 21 (11), 1441-1448, 2007 | 431 | 2007 |
| Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial MB Conde, A Efron, C Loredo, GRM De Souza, NP Graça, MC Cezar, ... The Lancet 373 (9670), 1183-1189, 2009 | 425 | 2009 |
| Treatment supporter to improve adherence to antiretroviral therapy in HIV-infected South African adults: a qualitative study JB Nachega, AR Knowlton, A Deluca, JH Schoeman, L Watkinson, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 43, S127-S133, 2006 | 244 | 2006 |
| Effect of improved tuberculosis screening and isoniazid preventive therapy on incidence of tuberculosis and death in patients with HIV in clinics in Rio de Janeiro, Brazil: a … B Durovni, V Saraceni, LH Moulton, AG Pacheco, SC Cavalcante, ... The Lancet infectious diseases 13 (10), 852-858, 2013 | 122 | 2013 |
| Randomized controlled trial of trained patient-nominated treatment supporters providing partial directly observed antiretroviral therapy JB Nachega, RE Chaisson, R Goliath, A Efron, MA Chaudhary, M Ram, ... Aids 24 (9), 1273-1280, 2010 | 112 | 2010 |
| The implementation of isoniazid preventive therapy in HIV clinics: the experience from the TB/HIV in Rio (THRio) study B Durovni, SC Cavalcante, V Saraceni, V Vellozo, G Israel, BS King, ... AIDS 24, S49-S56, 2010 | 88 | 2010 |
| T-SPOT.TBresponses during treatment of pulmonary tuberculosis S Ribeiro, K Dooley, J Hackman, C Loredo, A Efron, RE Chaisson, ... BMC infectious diseases 9, 1-9, 2009 | 86 | 2009 |
| Patient-nominated, community-based HIV treatment supporters: patient perspectives, feasibility, challenges, and factors for success in HIV-infected South African adults MM Duwell, AR Knowlton, JB Nachega, A Efron, R Goliath, C Morroni, ... AIDS Patient Care and STDs 27 (2), 96-102, 2013 | 52 | 2013 |
| Tuberculosis incidence among contacts of active pulmonary tuberculosis M Cailleaux-Cezar, D de A Melo, GM Xavier, CLG De Salles, ... The International Journal of Tuberculosis and Lung Disease 13 (2), 190-195, 2009 | 42 | 2009 |
| Tuberculosis control in a socially vulnerable area: a community intervention beyond DOT in a Brazilian favela ECC Soares, WM Vollmer, SC Cavalcante, AG Pacheco, V Saraceni, ... The International journal of tuberculosis and lung disease 17 (12), 1581-1586, 2013 | 38 | 2013 |
| A phase 2 randomized trial of a rifapentine plus moxifloxacin-based regimen for treatment of pulmonary tuberculosis MB Conde, FCQ Mello, RS Duarte, SC Cavalcante, V Rolla, M Dalcolmo, ... PLoS One 11 (5), e0154778, 2016 | 37 | 2016 |
| Point-of-care Arkansas method for measuring adherence to treatment with isoniazid RL Guerra, MB Conde, A Efron, C Loredo, G Bastos, RE Chaisson, ... Respiratory medicine 104 (5), 754-757, 2010 | 35 | 2010 |
| Yield of close contact tracing using two different programmatic approaches from tuberculosis index cases: a retrospective quasi-experimental study C Loredo, M Cailleaux–Cezar, A Efron, FCQ de Mello, MB Conde BMC pulmonary medicine 14, 1-8, 2014 | 26 | 2014 |
| Two-stage activity-safety study of daily rifapentine during intensive phase treatment of pulmonary tuberculosis R Dawson, K Narunsky, D Carman, N Gupte, A Whitelaw, A Efron, ... The International Journal of Tuberculosis and Lung Disease 19 (7), 780-786, 2015 | 22 | 2015 |
| Understanding and retention of trial-related information among participants in a clinical trial after completing the informed consent process F Mexas, A Efron, RR Luiz, M Cailleaux-Cezar, RE Chaisson, MB Conde Clinical Trials 11 (1), 70-76, 2014 | 22 | 2014 |
| Impact of immune reconstitution inflammatory syndrome on antiretroviral therapy adherence JB Nachega, C Morroni, RE Chaisson, R Goliath, A Efron, M Ram, ... Patient preference and adherence, 887-891, 2012 | 19 | 2012 |
| Adherence to tuberculosis preventive therapy measured by urine metabolite testing among people with HIV EA Kendall, B Durovni, NA Martinson, S Cavalacante, K Masonoke, ... Aids 34 (1), 63-71, 2020 | 14 | 2020 |
| Randomized trial of trained patient-nominated treatment supporters providing partial directly observed ART in South African adults initiating HIV therapy J Nachega, R Goliath, A Efron, M Chaudhary, M Ram, C Morroni 16th Conference on Retroviruses and Opportunistic Diseases, 2009 | 10 | 2009 |
| 419 Chaudhary MA, Bishai WR, Kritski AL, Chaisson RE. 2009. Moxifloxacin versus 420 ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, 421 … MB Conde, A Efron, C Loredo, GR De Souza, NP Graca, MC Cezar, ... Lancet 373, 1183-1189, 0 | 2 | |
| Evaluating Understanding Of The Informed Consent Process Among Research Subjects In A Tuberculosis Clinical Trial. Preliminary Results F Mexas B15. CLINICAL OUTCOMES RESEARCH METHODOLOGY, A2463-A2463, 2012 | 1 | 2012 |
